Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 5.5 to 4.
Financials
Financial year 2025
DEPROPHAR from Elsene, company number BE0413109340, closed financial year 2025 with a result of € 26,713 after tax. For that financial year DEPROPHAR recorded a gross margin of € 426,027 and equity of € 426,267. Compared with financial year 2024, the result moved from € 11,749 to € 26,713. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.
€ 426,267
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 26,713
▲ 127% vs 2024
Profit after tax over the fiscal year.
€ 59,213
▲ 72% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 178,267.
People and assets in 2025
4
▼ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 343,006
▼ 20% vs 2024
€ 85,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 26,337
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 7,834
▼ 60% vs 2024
€ 5,859 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 67,467
▲ 64% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 66,671
▲ 1% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 449,310 | € 498,026 | € 489,794 | € 426,027 | ▼ 13% |
| Profit after taxes | € -68,483 | € -7,652 | € 11,749 | € 26,713 | ▲ 127% |
| Equity | € 395,457 | € 387,805 | € 399,554 | € 426,267 | ▲ 7% |
| Total debts | € 170,151 | € 161,068 | € 127,547 | € 143,666 | ▲ 13% |
| Cash | € 55,237 | € 38,446 | € 34,380 | € 59,213 | ▲ 72% |
| Land & buildings | € 20,413 | € 12,497 | € 9,916 | € 9,916 | |
| Retained profit | € 147,457 | € 139,805 | € 151,554 | € 178,267 | ▲ 18% |
| Bank debt | € 48,079 | € 32,603 | € 19,355 | € 7,834 | ▼ 60% |
| Balance sheet total | € 565,607 | € 548,873 | € 527,101 | € 569,934 | ▲ 8% |
| Employees (FTE) | 6.1 | 5.5 | 5 | 4 | ▼ 1 |
By gross margin, DEPROPHAR ranks 6th of 21 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Elsene that publish figures (fiscal year 2025).
Key figures of DEPROPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about DEPROPHAR the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DEPROPHAR?
What happened at DEPROPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 26,713 (▲ 127% vs 2024). Source: NBB ↗
- New establishment in Elsene. KBO
- New establishment in Elsene. KBO
- Start of the company according to the CBE. KBO
In short
From € 68,483 loss in 2022 to € 26,713 profit in 2025.
Paid € 23,933 in corporate taxes since 2022.
Best year ever: 2025, with € 26,713 profit.
On average € 106,500 of value added per employee in 2025.
Management
Behind DEPROPHAR are FRANCOISE PERAU and MICHEL WOOG.
Directors
According to the 2025 annual accounts
FRANCOISE PERAU
Director
MICHEL WOOG
Director
Establishments
Establishment units
Physical locations of this company
Scepterstraat 6
1050 Elsene
Troonstraat 232
1050 Elsene
Active since 1 October 1973
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Elsene
Same main activity (Groothandel in farmaceutische en medische artikelen), 32 active companies in Elsene, largest first.
€ 164.7 million revenue · 2025
€ 96.9 million revenue · 2025
Boehringer Ingelheim Animal Health Belgium SA
€ 50.6 million revenue · 2025
€ 23.5 million revenue · 2025
€ 21.4 million revenue · 2026
€ 16.2 million revenue · 2025
Website
Technologies
Hosting & Email
Email provider
OVH Mail
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
deprophar.com
Registered
2018-07-03
Registrar
OVH, SAS
Expires
2026-07-03
Website info
Features
Security
Network
Details
- Company number
- 0413.109.340
- VAT number
- BE 0413.109.340
- Registered office
- Scepterstraat 6, 1050 Elsene
- Names & denominations
- DEPROPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 March 1973
- Peppol
- Active · Active since 22 Sept 2025
- Contact
- deprophar.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Detailhandel in drogisterijartikelen en onderhoudsproducten
Gespecialiseerde detailhandel in drogisterijartikelen en onderhoudsproducten
Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels